Esperion Therapeutics saw the highest growth of 3.99% in patent filings and 3.99% in grants in May in Q2 2024. Compared to Q1 2024, Q2 2024 saw no growth in patent filings and grants by 0.49%. GlobalData’s DataBook provides a comprehensive analysis of Esperion Therapeutics‘s patent filings and grants. Buy the databook here.
Smarter leaders trust GlobalData
Esperion Therapeutics has been focused on protecting inventions in United States(US) with four publications in Q2 2024
The United States(US) Patent Office dominates the patent filings and grants with nearly 50% filings and 20% grants. The United States(US), European Patent Office(EPO), Australia(AU), and Spain(ES) patent Office are among the top ten patent offices where Esperion Therapeutics is filings its patents. Among the top granted patent authorities, Esperion Therapeutics has 20% of its grants in United States(US), 20% in Spain(ES) and 20% in Croatia(HR).
Regeneron Pharmaceuticals and Amgen could be the strongest competitors for Esperion Therapeutics
Patents related to rare diseases lead Esperion Therapeutics's portfolio
Esperion Therapeutics has the highest number of patents in rare diseases. For rare diseases, nearly 100% of patents were filed and 100% of patents were granted in Q2 2024.
Cardiovascular disease related patents lead Esperion Therapeutics portfolio followed by hypercholesterolemia, and hyperlipidemia
Esperion Therapeutics has highest number of patents in cardiovascular disease followed by hypercholesterolemia, hyperlipidemia, myalgia (muscle pain), and polycystic kidney disease. For cardiovascular disease, nearly 40% of patents were filed and 50% of patents were granted in Q2 2024.
For comprehensive analysis of Esperion Therapeutics's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.
Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.
